Sign in

    Benjamin Mogil

    Research Analyst at Stifel Nicolaus

    Benjamin Mogil's questions to Regencell Bioscience Holdings (RGC) leadership

    Benjamin Mogil's questions to Regencell Bioscience Holdings (RGC) leadership • Q2 2016

    Question

    Benjamin Mogil from Stifel Nicolaus asked about the industry's screen supply growth, noting that major exhibitors seemed to be growing at a slower pace. He also inquired about the role of developers in financing new theatre construction.

    Answer

    Executive VP, CFO & Treasurer David H. Ownby explained that Regal's capital is prioritized for high-return recliner renovations, which increase market share without adding screens. Chairman & CEO Amy E. Miles added that overall industry growth is within historical norms and noted a positive shift where developers are increasingly interested in funding luxury theatre projects, creating new opportunities for the company.

    Ask Fintool Equity Research AI